We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App





Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event

By LabMedica International staff writers
Posted on 16 Dec 2020
Roche (Basel, Switzerland) showcased leading-edge technology at its virtual booth at 2020 AACC Annual Scientific Meeting with demonstrations of the company’s newest additions to the cobas family of analyzers.

At the AACC Virtual 2020 Annual Scientific Meeting & Clinical Lab Expo, Roche demonstrated its new cobas pro integrated solution that allows laboratories to experience a new improved level of simplicity while achieving mid to high volume clinical chemistry and immunochemistry testing needs. More...
Visitors to Roche’s virtual booth at AACC 2020 were able to see firsthand the newest innovations, including reduced maintenance, cobas AutoCal, and long on-board reagent stability. The cobas pro integrated solution includes the cobas ISE analytical unit that measures the concentration of sodium (Na+), potassium (K+) and chloride (Cl-), the all-new cobas c 503 analytical unit for clinical chemistry, and cobas e 801 analytical unit for immunochemistry. The state-of-the-art cobas pro offers a range of advanced features that help optimize workflow, improve productivity, and enhance reliability and turnaround times to support patient care.

Roche also gave viewers a peek behind the curtain to the innovations offered by cobas pure integrated solutions, the newest member of the cobas family of systems that is designed to deliver excellence, while at the same time simplifying daily work. Built on the latest technology, cobas pure integrated solutions combines clinical chemistry, immunoassay and ISE1 diagnostic testing on a footprint of just two square meters to achieve low to mid volume testing needs.



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.